title: Anti-granuloma activity of Coriandrum sativum in experimental models.
abstract: BACKGROUND
  Coriandrum sativum has been used in the traditional systems of medicine for management of arthritis and other inflammatory disorders.
  
  
  OBJECTIVE
  In this study, we have evaluated the anti-inflammatory and anti-granuloma activities of Coriandrum sativum hydroalcoholic extract (CSHE) in experimental models.
  
  
  METHODS
  The anti-inflammatory activity of CSHE was evaluated using carrageenan-induced paw edema model and the anti-granuloma activity of CSHE was evaluated using the subcutaneous cotton pellet implantation-induced granuloma formation and stimulation of peritoneal macrophages with complete Freund's adjuvant. Serum tumor necrosis factor-α (TNF-α), IL-6, IL-1 β levels, and peritoneal macrophage expression of TNF-R1 were evaluated as markers of global inflammation.
  
  
  RESULTS
  CSHE at the highest dose tested (32 mg/kg) produced a significant reduction (P < 0.05) in paw edema after carrageenan administration. CSHE treatment also reduced dry granuloma weight in all treated animals. Serum IL-6 and IL-1 β levels were significantly (P < 0.05) lower in the CSHE (32 mg/kg)-treated group as compared to control. Although there was an increase in serum TNF-α level in the CSHE-treated group as compared to control, TNF-R1 expression on peritoneal macrophages was found to be reduced.
  
  
  CONCLUSIONS
  Thus, the result of this study demonstrates the anti-inflammatory and anti-granuloma activities of CSHE in experimental models, and validates its traditional use for the management of arthritis and other inflammatory disorders.
authors.affiliation: Department of Pharmacology, All India Institute of Medical Sciences, New Delhi, India.
authors.forename: Vinod
authors.initials: V
authors.lastname: Nair
authors.forename: Surender
authors.initials: S
authors.lastname: Singh
authors.forename: Yogendra Kumar
authors.initials: YK
authors.lastname: Gupta
keywords: Adjuvant; carrageenan; cotton pellet granuloma; pro-inflammatory cytokines